| Product Code: ETC9971020 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Mycoses Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Mycoses Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Mycoses Treatment Market - Industry Life Cycle |
3.4 United States (US) Mycoses Treatment Market - Porter's Five Forces |
3.5 United States (US) Mycoses Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United States (US) Mycoses Treatment Market Revenues & Volume Share, By Fungi Type, 2021 & 2031F |
3.7 United States (US) Mycoses Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 United States (US) Mycoses Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.9 United States (US) Mycoses Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Mycoses Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of fungal infections in the United States |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of mycoses |
4.2.3 Technological advancements in diagnostic techniques and treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with advanced antifungal medications |
4.3.2 Limited availability of specialized healthcare facilities for mycoses treatment in certain regions |
5 United States (US) Mycoses Treatment Market Trends |
6 United States (US) Mycoses Treatment Market, By Types |
6.1 United States (US) Mycoses Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Mycoses Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United States (US) Mycoses Treatment Market Revenues & Volume, By Azoles, 2021- 2031F |
6.1.4 United States (US) Mycoses Treatment Market Revenues & Volume, By Echinocandins, 2021- 2031F |
6.1.5 United States (US) Mycoses Treatment Market Revenues & Volume, By Allylamines, 2021- 2031F |
6.1.6 United States (US) Mycoses Treatment Market Revenues & Volume, By Polyenes, 2021- 2031F |
6.1.7 United States (US) Mycoses Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Mycoses Treatment Market, By Fungi Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Mycoses Treatment Market Revenues & Volume, By Dermatophytes, 2021- 2031F |
6.2.3 United States (US) Mycoses Treatment Market Revenues & Volume, By Yeasts, 2021- 2031F |
6.2.4 United States (US) Mycoses Treatment Market Revenues & Volume, By Molds, 2021- 2031F |
6.2.5 United States (US) Mycoses Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Mycoses Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Mycoses Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Mycoses Treatment Market Revenues & Volume, By Tropical, 2021- 2031F |
6.3.4 United States (US) Mycoses Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Mycoses Treatment Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Mycoses Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Mycoses Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Mycoses Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 United States (US) Mycoses Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Mycoses Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Mycoses Treatment Market Revenues & Volume, By Hospital Pharmac, 2021- 2031F |
6.5.3 United States (US) Mycoses Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Mycoses Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Mycoses Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Mycoses Treatment Market Export to Major Countries |
7.2 United States (US) Mycoses Treatment Market Imports from Major Countries |
8 United States (US) Mycoses Treatment Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation |
8.2 Number of clinical trials for new antifungal drugs being conducted in the United States |
8.3 Patient adherence rates to prescribed mycoses treatment regimens |
9 United States (US) Mycoses Treatment Market - Opportunity Assessment |
9.1 United States (US) Mycoses Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United States (US) Mycoses Treatment Market Opportunity Assessment, By Fungi Type, 2021 & 2031F |
9.3 United States (US) Mycoses Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 United States (US) Mycoses Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
9.5 United States (US) Mycoses Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Mycoses Treatment Market - Competitive Landscape |
10.1 United States (US) Mycoses Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Mycoses Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here